Newsletter Archive
-
03.18.24 -- Relational Risk Analysis For The Bio/Pharma Industry
3/18/2024
03/18/24 Bioprocess Online Newsletter
-
03.15.24 -- Tangential Flow Filtration 101 — The Tech, The Need, And The Market
3/15/2024
03/15/24 Bioprocess Online Newsletter
-
03.13.24 -- Explore Revolutionary Research Shaping Medicine
3/13/2024
03/13/24 Bioprocess Online Newsletter
-
03.13.24 -- FDA Issues Draft Guidance For Cell & Gene Therapy Potency Assurance
3/13/2024
03/13/24 Bioprocess Online Newsletter
-
03.12.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
3/12/2024
03/12/24 Bioprocess Online Newsletter
-
03.11.24 -- Overcoming Advanced Therapy Development Hurdles
3/11/2024
03/11/24 Bioprocess Online Newsletter
-
03.11.24 -- 21 New Downstream Technologies Being Considered To Fix Capacity Problems
3/11/2024
03/11/24 Bioprocess Online Newsletter
-
03.08.24 -- New Episodes: Yescarta's Reduced Median Turnaround Time, Inhalable mRNA and more!
3/8/2024
03/08/24 Bioprocess Online Newsletter
-
03.08.24 -- Driving Pharma/Biotech Capacity With Smart Manufacturing
3/8/2024
03/08/24 Bioprocess Online Newsletter
-
03.07.24 -- Insights And Practical Solutions For Environmental Monitoring
3/7/2024
03/07/24 Bioprocess Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more